Gentris Corp. has opened a new genomic biomarker testing and biorepository services lab in Shanghai, China. Gentris Shanghai will provide GCLP-compliant testing and biobanking services for global pharmaceutical clients under international standards.   “The launch of Gentris Shanghai is a tremendous milestone for our company,” said Dr. Amelia Wall Warner, Gentris president and chief executive officer. “Gentris is creating an international quality, global organization capable of ...